ES469749A1 - Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol. - Google Patents

Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.

Info

Publication number
ES469749A1
ES469749A1 ES469749A ES469749A ES469749A1 ES 469749 A1 ES469749 A1 ES 469749A1 ES 469749 A ES469749 A ES 469749A ES 469749 A ES469749 A ES 469749A ES 469749 A1 ES469749 A1 ES 469749A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical formulation
drug
notroimidazole
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469749A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES469749A1 publication Critical patent/ES469749A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES469749A 1977-05-14 1978-05-11 Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol. Expired ES469749A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2037977 1977-05-14

Publications (1)

Publication Number Publication Date
ES469749A1 true ES469749A1 (es) 1978-12-16

Family

ID=10144988

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469749A Expired ES469749A1 (es) 1977-05-14 1978-05-11 Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.

Country Status (16)

Country Link
JP (1) JPS542315A (fr)
AU (1) AU504551B1 (fr)
BE (1) BE867040A (fr)
DE (1) DE2820992A1 (fr)
DK (1) DK212678A (fr)
ES (1) ES469749A1 (fr)
FI (1) FI781507A7 (fr)
FR (1) FR2390162A1 (fr)
IL (1) IL54687A0 (fr)
IT (1) IT1115599B (fr)
LU (1) LU79655A1 (fr)
NL (1) NL7805158A (fr)
NO (1) NO781688L (fr)
PT (1) PT68034B (fr)
SE (1) SE7805471L (fr)
ZA (1) ZA782736B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023B2 (fr) * 1979-08-11 1992-11-11 Bayer Ag Agents antimycotiques à libération plus élevée des principes actifs
FR2624736B1 (fr) * 1987-12-16 1991-03-22 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole
CN104127379A (zh) * 2014-08-14 2014-11-05 珠海亿邦制药股份有限公司 一种奥硝唑注射液及其制备方法
CN110538144A (zh) * 2019-06-13 2019-12-06 南京瓦尔生物医药有限公司 一种奥硝唑注射液和s-奥硝唑注射液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition

Also Published As

Publication number Publication date
NO781688L (no) 1978-11-15
IL54687A0 (en) 1978-07-31
PT68034A (en) 1978-06-01
IT7823351A0 (it) 1978-05-12
DE2820992A1 (de) 1978-12-07
PT68034B (en) 1979-10-24
JPS542315A (en) 1979-01-09
FR2390162A1 (fr) 1978-12-08
LU79655A1 (fr) 1979-12-06
BE867040A (fr) 1978-11-13
IT1115599B (it) 1986-02-03
FI781507A7 (fi) 1978-11-15
SE7805471L (sv) 1978-11-15
DK212678A (da) 1978-11-15
ZA782736B (en) 1979-05-30
NL7805158A (nl) 1978-11-16
AU504551B1 (en) 1979-10-18

Similar Documents

Publication Publication Date Title
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
SE8701900D0 (sv) Pulsed drug delivery
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
GB2007091A (en) Ophthalmic composition
SE7613959L (sv) Antibiotisk komposition och forfarande for framstellning derav
DE2861729D1 (en) Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
MX27046A (es) 5-arilalquil-4-alcoxy-2(5h)-furanonas, productos intermedios y procedimiento para su preparacion asi como su aplicacion como sustancia activa terapeutica.
FI813349A7 (fi) 1-Karboksialkanoyyli-indoliini-2- karboksyylihappoja, menetelmiä niiden valmistamiseksi, näitä yhdisteitsisältäviä farmaseuttisia valmisteita ja niiden terapeuttinen käyttö.
ES485063A1 (es) Un procedimiento para preparar derivados de acido acetico
ES2055860T3 (es) Derivados 2-aminopirimidinona.
DK0490772T3 (da) 1,4-disubstituerede piperaziner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, der indeholder dem
ES421538A1 (es) Procedimiento para la obtencion de derivados de alcanolami-na.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
FI813422A7 (fi) 1-Karboksi-atsa-alkanoyyli- indoliini- karboksyylihappoja, menetelmiä niiden valmistamiseksi, näitä yhdisteitsisältäviä farmaseuttisia valmisteita ja niiden terapeuttinen käyttö.
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2145360T3 (es) Sales cristalinas y estables de acido tetrahidrofolico.
FR2581382B1 (fr) Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
ES410825A1 (es) Procedimiento para la preparacion de derivados de quino- leina.
SE7902866L (sv) 3-0-(beta-d-glukuronopyranosyl)-sojasapogenol b
IT7926854A0 (it) Derivato di creatinolo o-fosfato ad azione terapeutica, procedimento per la sua preparazione e relativ-e composizioni farmaceutiche.
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
ES2151891T3 (es) Derivados de ciclohexano sustituidos con imidazolilo.
IT7823102A0 (it) Derivati di acidi azolil-alcan-carbossilici, procedimento per la loro preparazione e loro impiego come funghicidi.